Royal Philips announced the launch of Verida, the world's first AI-powered spectral CT scanner, at the RSNA 2025 conference. This new technology improves CT scans by using AI to reduce noise, improve image quality, and speed up the process.
Philips' spectral CT has been installed in over 800 locations worldwide and is supported by numerous research publications. It works by measuring how tissues absorb different levels of x-ray energy, allowing it to distinguish between materials that look the same on regular CT scans. Philips pioneered this technology, which allows multiple spectral results to be obtained from a single scan without compromising performance or scan time.
With AI connected across the whole medical imaging procedure, Verida provides premium image quality with very little noise, as well as high-definition conventional images. It also reduces the radiation dose for patients without sacrificing image quality, and can cut down on energy use by up to 45%.
Verida can process 145 images per second, meaning entire exams can be completed in less than 30 seconds—twice as fast as before, enabling up to 270 exams a day. With AI-driven spectral imaging as well as an advanced dual-layer detector, Verida provides faster, more efficient scans, helping doctors get more detailed information from just one scan.
According to Coherent Market Insights, the Medical Technology Platform Market is projected to grow at a CAGR of 11.4% during 2025 to 2032. Currently, the market is at USD 31.59 Billion in 2025 and is expected to be around USD 67.26 Billion by 2032. The medical technology platform market is expected to grow significantly over the next five years. This growth will be driven by rising healthcare costs globally and the need for more affordable and innovative healthcare solutions.
“The clinical benefits of Verida will fundamentally change my approach to cardiac imaging,” said Prof. Eliseo Vañó Galván, cardiovascular radiologist, Chairman of the CT & MR Department at Hospital Nuestra. Sra. Del Rosario, Madrid, Spain. “With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients – building toward a fully spectral CT department. We evaluated many systems, including photon-counting CT, but chose Philips because it delivers the precision we need in a streamlined, easy-to-use platform. The result is greater diagnostic confidence and the potential to reduce the need for invasive angiograms – not just in cardiology, but across other clinical areas as well.
“Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow, all to help clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways – in a single scan,” said Dan Xu, Business Leader of CT at Philips. “While photon-counting CT adds complexity, is yet to move from the research arena into clinical practice, Philips spectral CT has been a clinical workhorse for more than a decade and delivers comparable or better clinical outcomes, standing up to the most demanding throughput and at significantly lower total cost of ownership”.
Source:
News Release: Royal Philips
Company: Royal Philips
